Roflumilast
Also known as: Daliresp, Daxas, 3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide, 3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide, B 9302-107, BY 217, BYK 20869, Roflost, Roster, CS-1960, APTA 2217
Roflumilast (CAS 162401-32-3) is a compound in the Organohalogen Compounds category listed in the Jingsj chemical database. It has the molecular formula C17H14Cl2F2N2O3 and a molecular weight of 403.207 g/mol. Key properties include a melting point of 158°C, a boiling point of 430.6±45.0 °C at 760 mmHg, a density of 1.5±0.1 g/cm3 and a flash point of 214.2±28.7 °C. It is classified under GHS with signal word Warning and hazard statements H315 — Causes skin irritation, H319 — Causes serious eye irritation and H335 — May cause respiratory irritation. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.
- CAS No.
- 162401-32-3
- Jingsj CID
- J-1970767-7
- Molecular Formula
- C17H14Cl2F2N2O3
- Molecular Weight
- 403.207 g/mol
- Category
- Organohalogen Compounds
- Last updated
- 8/21/2026
No offers for this compound yet.
Request a quotePhysicochemical Properties
| Melting Point | 158°C |
|---|---|
| Boiling Point | 430.6±45.0 °C at 760 mmHg |
| Density | 1.5±0.1 g/cm3 |
| Flash Point | 214.2±28.7 °C |
| Exact Mass | 402.034943 |
| PSA | 60.45000 |
| LogP | 4.84 |
| Vapor Pressure | 0.0±1.0 mmHg at 25°C |
| Refractive Index | 1.604 |
| Storage Conditions | Refrigerator |
GHS Safety & Compliance
- H315 — Causes skin irritation
- H319 — Causes serious eye irritation
- H335 — May cause respiratory irritation
Activity & Biological Data
| Target | IC50: 0.7 nM (PDE4A1), 0.9 nM (PDE4A4), 0.7 nM (PDE4B1), 0.2 nM (PDE4B2)[1] |
|---|---|
| Additional Information | [1]. Hatzelmann A, et al. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2010 Aug;23(4):235-56. [2]. Rabe KF. Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease. Br J Pharmacol. 2011 May;163(1):53-67. [3]. Hatzelmann A, et al. Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. J Pharmacol Exp Ther. 2001 Apr;297(1):267-79. [4]. Richmond BW, et al. Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency. Nat Commun. 2016 Apr 5;7:11240. [5]. Ding H, et al. Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast. Int Urol Nephrol. 2017 Jul 29. |
Frequently Asked Questions
What is the CAS number of Roflumilast?
The CAS number of Roflumilast is 162401-32-3.
What are the molecular formula and molecular weight of Roflumilast?
Roflumilast has molecular formula C17H14Cl2F2N2O3 and molecular weight 403.207 g/mol.
Is Roflumilast hazardous?
Roflumilast has GHS signal word Warning and hazard statements H315 — Causes skin irritation; H319 — Causes serious eye irritation; H335 — May cause respiratory irritation.
Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.
Last updated:
How to cite: Jingsj. "Roflumilast (CAS 162401-32-3)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-1970767-7 (accessed 2026-11-06).
Data for reference only; verify product details with suppliers before purchase.